24/7 Customer Support

Talk to Louis

+1 718 618 4302

Publication dates

All regions

Melanoma Industry, October 2014 Market Reports from Top Publishers

You might be interested in: cancer, breast cancer, colorectal cancer, more »


 
1-20 of about 8 600 reports for Melanoma

Malignant Melanoma: KOL Insight

Malignant Melanoma: KOL Insight

  • $ 6 495
  • Industry report
  • October 2014
  • by Firstword Pharma

... Malignant melanoma treatments and what they see as critical advantages/disadvantages affecting their to prescribe.Appreciate the important factors affecting the fast ...

Genoptix, Inc. (Symbol:GXDX) SWOT Analysis, Strategy, Revenues and Profits

Genoptix, Inc. (Symbol:GXDX) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • October 2014
  • by Global Data

... Its product also provides molecular profiles for myelodysplastic syndromes (mds), myeloid malignancies, acute myeloid leukemia (aml) in heme, and melanoma for skin cancer. The company is a wholly owned ...

Nevada Cancer Institute SWOT Analysis, Strategy, Revenues and Profits

Nevada Cancer Institute SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • October 2014
  • by Global Data

... Information, histology lab, research imaging facility, journal club, cancer immunotherapy or biotherapy, breast cancer, clinical sciences and melanoma. Nci also conducts treatment programs such as clinical ...

BioMarker Strategies, LLC - Product Pipeline Analysis, 2014 Update

BioMarker Strategies, LLC - Product Pipeline Analysis, 2014 Update

  • $ 750
  • Company report
  • September 2014
  • by Global Data

... National cancer institute contract to develop companion diagnostic test to select optimal therapy for melanoma patients 23oct 03, 2012: biomarker strategies appoints jack davis as executive chairman 23 ...

Physician Views: The PD-1 inhibitor class lands - how do US oncologists expect to initially use Merck & Co.%s Keytruda?

Physician Views: The PD-1 inhibitor class lands - how do US oncologists expect to initially use Merck & Co.%s Keytruda?

  • $ 645
  • Industry report
  • September 2014
  • by Firstword Pharma

... Line melanoma patients they anticipate prescribing a combination of keytr (pembrolizumab) and yervoy (ipilimumab) - in an off-label capacity - six to nine months after launch ...

Mitomics Inc. - Product Pipeline Analysis, 2014 Update

Mitomics Inc. - Product Pipeline Analysis, 2014 Update

  • $ 750
  • Company report
  • September 2014
  • by Global Data

... Pancreatic cancer, endometriosis, melanoma, skin cancer and other dermatological conditions. Mitomics's prostate mitomic test is a blood-based screening test for the prediction of prostate cancer following ...

Medical Affairs Reputations in Oncology: Oncologists Rate Key Products and Companies

Medical Affairs Reputations in Oncology: Oncologists Rate Key Products and Companies

  • $ 3 900
  • Industry report
  • August 2014
  • by Firstword Pharma

... In the areas of breast cancer, melanoma, nsclc, and renal cell carcinomaunderstand the key issues for which physicians require medical affairs team support ...

Trends in Therapeutic Partnering

Trends in Therapeutic Partnering

  • $ 3 995
  • Industry report
  • August 2014
  • by Currentpartnering

... Malaria partnering in numberstop malaria partnering deals by valuemost active malaria partnering companies33. melanomamelanoma partnering in numberstop melanoma partnering deals by value ...

Melanoma Partnering 2009-2014

Melanoma Partnering 2009-2014

  • $ 995
  • Industry report
  • August 2014
  • by Currentpartnering

... To the contract. Chapter 4 provides a comprehensive directory of melanoma partnering deals signed and announced since 2009. The chapter is organized by company a-z, stage of development at signing, deal ...

Cancer Research Institute - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Cancer Research Institute - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • July 2014
  • by Global Data

... Immunology and cancer immunology research. It conducts clinical trials for several cancer types such as breast cancer, colorectal cancer, lung cancer, melanoma and prostate cancer. The institute ...

About 1 000 reports for Melanoma

Download Unlimited Documents from Trusted Public Sources

Pathology Description in Europe - Forecast

  • May 2014
    5 pages
  • Melanoma  

    Drug  

  • Europe  

    Italy  

    Germany  

View report >

1 Companies for Melanoma

Read our Company Profiles

Eli Lilly and Co.

United States

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.